The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost Growth

Introduction

Cardiac Resynchronization Therapy (CRT) devices have been studied clinically since 1998, and have been on the US market since the FDA approval of the first product in 2001.

CRT (also known as biventricular pacing) is used for the prevention and treatment of congestive heart failure caused by dilated cardiomyopathy. CRT devices typically have three leads implanted into one atrium and two ventricles of the heart. The wires that carry the electrical signals in a pacemaker connect to an electrical pulse generator placed under the skin in the upper chest. In addition to the two leads (right atrium and right ventricle) used by a common pacemaker, the CRT device has a third lead that is positioned in a vein on the surface of the left ventricle. This system allows the CRT device to simultaneously stimulate the left and right ventricles and restore a coordinated or “synchronous” heart beat pattern. This is also referred to as “bi-ventricular pacing” because both ventricles are electrically paced at the same time.

Scope

- The study provides information on the Cardiac Resynchronization Therapy (CRT) market.
- It discusses briefly the clinical trial results that assist market growth.
- It also covers the global CRT market, in terms of both geography and revenue.

Highlights

Reasons to buy

- Be abreast of key events in the medical device industry
- Make informed decisions by understanding the rationale behind key events
- Align your market strategies with the events which can impact your business
- Develop proactive marketing strategies and business plans through real-time updates of pipeline products, technologies and financial deals

Report Highlights

[Cerrar las informaciones del articulo de mercado]

TABLE OF CONTENTS

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost Growth 6
2.1 Overview 6
2.2 Clinical Trial Results Boosting Market Growth 7
2.2.1 CARE HF 7
2.2.2 COMPANION 7
2.2.3 MADIT CRT 7
2.2.4 REVERSE 8
2.3 The Global Market for CRT Devices: US Remains the Leader 9
2.4 Cardiac Resynchronization Therapy Market, Revenue ($m), US, Historic 10
2.5 Cardiac Resynchronization Therapy Market, Revenue ($m), US, Forecast 11
2.6 Market Dynamics 12
2.6.1 Market Drivers 12
2.6.2 Market Restraints 12
2.7 Competitive Landscape 13
3 Appendix 14
3.1 GlobalData Research Methodology 14
3.2 Secondary Research 15
3.3 Primary Research 16
3.4 Models 16
3.5 Forecasts 17
3.6 Expert Panel Validation 17
3.7 Currency Conversion 18
3.8 Contact Us 19
3.9 Disclaimer 19
[Cerrar la tabla de contenidos]

LIST OF TABLES

1.1 List of Tables
Table 1: Cardiac Resynchronization Therapy, Revenue ($m), Cross Geographic Comparison, 2008 9
Table 2: Cardiac Resynchronization Therapy, Revenue ($m), US, 2000 – 2008 10
Table 3: Cardiac Resynchronization Therapy, Revenue ($m), US, 2008 – 2015 11
Table 4: USD to Local Currency, Average Exchange Rate 2008 18
LIST OF FIGURES

1.2 List of Figures
Figure 1: Cardiac Resynchronization Therapy, Revenue (%), Cross Geographic Comparison, 2008 9
Figure 2: Cardiac Resynchronization Therapy, Revenue ($m), US, 2000 – 2008 10
Figure 3: Cardiac Resynchronization Therapy, Revenue ($m), US, 2008 – 2015 11
Figure 4: Cardiac Resynchronization Therapy, Company Share (%), 2008 13
Figure 5: GlobalData Methodology 15
[Ocultar lista de tablas / figuras]